Amphetamine treatment increases corticotropin-releasing factor receptors in the dorsal raphe nucleus

Neuroscience Research

Volumn 62, Issue 1, 2008, Pages 62-65

  Pringle, Ronald B ^a   Mouw, Nicholas J ^a   Lukkes, Jodi L ^a   Forster, Gina L ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Amphetamine; Anxiety; CRF; Dorsal raphe nucleus; Rat; Serotonin

Indexed keywords

AMPHETAMINE; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEROTONINERGIC SYSTEM;

ADRENAL CORTEX HORMONES; AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; ANXIETY DISORDERS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; MALE; MESENCEPHALON; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS, PSYCHOLOGICAL; UP-REGULATION;

EID: 48049113459     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.05.009     Document Type: Article

References (19)

1. Amat J., Tamblyn J.P., Paul E.D., Bland S.T., Amat P., Foster A.C., Watkins L.R., and Maier S.F. Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 129 (2004) 509-519
2. Bale T.L. Sensitivity to stress: dysregulation of CRF pathways and disease development. Horm. Behav. 48 (2005) 1-10
3. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., and Campeau S. Differential expression of 5-HT1A, α1b adrenergic, CRH-R1 and CRH-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp. Neurol. 474 (2004) 364-378
4. Forster G.L., Feng N., Watt M.J., Mouw N.J., Korzan W.J., Summers C.H., and Renner K.J. Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience 141 (2006) 1047-1055
5. Forster G.L., Flanigan J.L., Scholl J.L., Barr J.L., Watt M.J., and Renner K.J. Alterations to anxiety and neural levels of corticotropin-releasing factor following amphetamine treatment. Soc. Neurosci. Abs. 65 (2007) 27
6. Hammack S.E., Schmid M.J., LoPresti M.L., Der-Avakian A., Pellymounter M.A., Foster A.C., Watkins L.R., and Maier S.F. Corticotrophin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J. Neurosci. 23 (2003) 1019-1025
7. Koob G.F. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur. Neuropsychopharmacol. 13 (2003) 442-452
8. Lindahl J.S., and Keifer J. Glutamate receptor subunits are altered in forebrain and cerebellum in rats chronically exposed to the NMDA receptor antagonist phencyclidine. Neuropsychopharmacology 29 (2004) 2065-2073
9. Lowry C.A., Rodda J.E., Lightman S.L., and Ingram C.D. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J. Neurosci. 20 (2000) 7728-7736
10. Lukkes J.L., Forster G.L., Renner K.J., and Summers C.H. Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens. Eur. J. Pharmacol. 578 (2008) 185-193
11. Mo B., Feng N., Renner K.J., and Forster G.L. Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors. Brain Res. Bull. 76 (2008) 493-498
12. Parsons L.H., and Justice Jr. J.B. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606 (1993) 195-199
13. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 3rd ed. (1997), Academic Press, New York
14. Pernar L., Curtis A.L., Vale W.W., Rivier J.E., and Valentino R.J. Selective activation of corticotrophin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J. Neurosci. 24 (2004) 1311-1350
15. Perrine S.A., Sheikh I.S., Nwaneshiudu C.A., Schroeder J.A., and Unterwald E.M. Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat. Neuropharmacology 54 (2008) 355-364
16. Price M.L., Kirby L.G., Valentino R.J., and Lucki I. Evidence for corticotropin-releasing factor regulation of serotonin in the lateral septum during acute swim stress: adaptation produced by repeated swimming. Psychopharmacology 162 (2002) 406-414
17. Rotllant D., Nadal R., and Armario A. Differential effects of stress and amphetamine administration on Fos-like protein expression in corticotropin releasing factor-neurons of the rat brain. Dev. Neurobiol. 67 (2007) 702-714
18. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., and Telegdy G. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res. 675 (1995) 89-97
19. Shepard J.D., and Myers D.A. Strain differences in anxiety-like behavior: association with corticotropin-releasing factor. Behav. Brain Res. 186 (2008) 239-245